✦ LIBER ✦

Results of a diallel trial and a breeding experiment for in vitro aptitude in maize

✍ Scribed by M. Beckert; Cao Ming Qing

Publisher: Springer
Year: 1984
Tongue: English
Weight: 353 KB
Volume: 68
Category: Article
ISSN: 0040-5752
DOI: 10.1007/bf00266898

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suramin for germ cell tumors. In vitro g

Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial

✍ Robert J. Motzer; Ethan Dmitrovsky; Wilson H. Miller Jr.; William P. Tong; Dean 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Use of L-cysteine in bread baking—result

Use of L-cysteine in bread baking—results of a multi-generation feeding experiment with breeding rats

✍ D. L. Frape; J. Wilkinson; L. G. Chubb; A. M. Buchanan; J. B. M. Coppock 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

all-trans retinoic acid for treating ger

all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trial

✍ Mark M. Moasser; Robert J. Motzer; Kei-Siong Khoo; Peter Lyn; Barbara A. Murphy; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB

Design and Validation of a Motion Stage

Design and Validation of a Motion Stage for In Vitro MR Experiments

✍ Yong Zhou; Timothy J. Carroll; Thomas M. Grist; Richard Frayne 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Irradiation behaviour of a tritium breed

Irradiation behaviour of a tritium breeding material, γ-LiAlO2- results of two in-pile experiments: ALICE I and ALICE II

✍ F. Botter; B. Rasneur; E. Roth 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 930 KB

Effects of Vitaxin®, a novel therapeutic

Effects of Vitaxin®, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro

✍ Azza Gramoun; Seema Shorey; Jill D. Bashutski; S. Jeffrey Dixon; Stephen M. Sims 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB 👁 1 views

## Abstract The integrin αvβ3 mediates cell–matrix interactions. Vitaxin®, a humanized monoclonal antibody that blocks human and rabbit αvβ3 integrins, is in clinical trials for metastatic melanoma and prostate cancer. αvβ3 is the predominant integrin on osteoclasts, the cells responsible for bone